HOME > 상세정보

상세정보

Drugs during pregnancy and lactation [electronic resource] : treatment options and risk assessment / 2nd ed

Drugs during pregnancy and lactation [electronic resource] : treatment options and risk assessment / 2nd ed

자료유형
E-Book(소장)
개인저자
Schaefer, Christof. Peters, P. W. J. (Paul W. J.). Miller, Richard K. (Richard Kermit), 1946-.
서명 / 저자사항
Drugs during pregnancy and lactation [electronic resource] : treatment options and risk assessment / edited by Christof Schaefer, Paul Peters, and Richard K. Miller.
판사항
2nd ed.
발행사항
Amsterdam ;   London :   Elsevier,   2007.  
형태사항
1 online resource (xxv, 875 p.) : ill.
기타형태 저록
Print version:   Drugs during pregnancy and lactation.   2nd ed.   Amsterdam ; London : Elsevier, 2007   9780444520722   0444520724   (OCoLC)170029613  
ISBN
9780080549774 (electronic bk.) 0080549772 (electronic bk.)
요약
The latest edition is the resource for any practicing OB/GYN, family physician, midwife, or pharmacist who prescribes medicinal products to or evaluates environmental or occupational exposures in women who are or may become pregnant. Based on the highly successful seven German editions of this reference, the up-to-date drug listings have been revised into a handy pocket guide color tabbed for quick access to important information. Easy to reference each drug is listed discussing the side effects, general impact on organ systems, potential toxicity, and risks before offering dosage recommendati.
일반주기
Title from e-Book title page.  
Previous edition: 2001.  
내용주기
2.2. Antiallergic drugs and desensitization -- 2.2.1. Antihistamines (H[sub(1)]-blocker) -- 2.2.2. Glucocorticosteroids -- 2.2.3. Mast cell stabilizers -- 2.2.4. Immunotherapy -- 2.3. Antiasthmatic and cough medication -- 2.3.1. Asthma and pregnancy -- 2.3.2. Selective ←(Sb←(B[sub(2)]-adrenergic agonists -- 2.3.3. Corticosteroids -- 2.3.4. Anticholinergic drugs -- 2.3.5. Theophylline -- 2.3.6. Cromoglycate, nedocromil, and lodoxamide -- 2.3.7. Other mast cell inhibitors -- 2.3.8. Antileukotrienes -- 2.3.9. Monoclonal antibodies and other asthma medications -- 2.3.10. Expectorants and mucolytic agents -- 2.3.11. Antitussives.
서지주기
Includes bibliographical references and index.
이용가능한 다른형태자료
Issued also as a book.  
일반주제명
Pregnant women --Drug use. Pregnant women --Medical care. Obstetrical pharmacology --Handbooks, manuals, etc. Fetus --Effect of drugs on --Handbooks, manuals, etc. Newborn infants --Effect of drugs on --Handbooks, manuals, etc. Infant, Newborn.
바로가기
ScienceDirect   URL
000 00000cam u2200205 a 4500
001 000045943749
005 20180622173016
006 m d
007 cr
008 071002s2007 ne a obf 001 0 eng d
020 ▼a 9780080549774 (electronic bk.)
020 ▼a 0080549772 (electronic bk.)
035 ▼a (OCoLC)173609891 ▼z (OCoLC)162586970 ▼z (OCoLC)786502945
040 ▼a N$T ▼b eng ▼e pn ▼c N$T ▼d YDXCP ▼d OCLCQ ▼d EBLCP ▼d NRU ▼d OCLCQ ▼d KOS ▼d OCLCQ ▼d WAU ▼d OPELS ▼d BUF ▼d OCLCF ▼d OPELS ▼d OCLCQ ▼d OCLCO ▼d NLGGC ▼d OCL ▼d OCLCQ ▼d YDX ▼d TOA ▼d AGLDB ▼d JBG ▼d Z5A ▼d OCLCO ▼d ZCU ▼d MERUC ▼d OCLCQ ▼d 211009
049 ▼a TEFA
050 0 0 ▼a RG627.6.D79 ▼b D796 2007
082 0 4 ▼a 618.32 ▼2 23
084 ▼a 618.32 ▼2 DDCK
090 ▼a 618.32
245 0 0 ▼a Drugs during pregnancy and lactation ▼h [electronic resource] : ▼b treatment options and risk assessment / ▼c edited by Christof Schaefer, Paul Peters, and Richard K. Miller.
250 ▼a 2nd ed.
260 ▼a Amsterdam ; ▼a London : ▼b Elsevier, ▼c 2007.
300 ▼a 1 online resource (xxv, 875 p.) : ▼b ill.
500 ▼a Title from e-Book title page.
500 ▼a Previous edition: 2001.
504 ▼a Includes bibliographical references and index.
505 0 0 ▼g 2.2. ▼t Antiallergic drugs and desensitization -- ▼g 2.2.1. ▼t Antihistamines (H[sub(1)]-blocker) -- ▼g 2.2.2. ▼t Glucocorticosteroids -- ▼g 2.2.3. ▼t Mast cell stabilizers -- ▼g 2.2.4. ▼t Immunotherapy -- ▼g 2.3. ▼t Antiasthmatic and cough medication -- ▼g 2.3.1. ▼t Asthma and pregnancy -- ▼g 2.3.2. ▼t Selective ←(Sb←(B[sub(2)]-adrenergic agonists -- ▼g 2.3.3. ▼t Corticosteroids -- ▼g 2.3.4. ▼t Anticholinergic drugs -- ▼g 2.3.5. ▼t Theophylline -- ▼g 2.3.6. ▼t Cromoglycate, nedocromil, and lodoxamide -- ▼g 2.3.7. ▼t Other mast cell inhibitors -- ▼g 2.3.8. ▼t Antileukotrienes -- ▼g 2.3.9. ▼t Monoclonal antibodies and other asthma medications -- ▼g 2.3.10. ▼t Expectorants and mucolytic agents -- ▼g 2.3.11. ▼t Antitussives.
520 ▼a The latest edition is the resource for any practicing OB/GYN, family physician, midwife, or pharmacist who prescribes medicinal products to or evaluates environmental or occupational exposures in women who are or may become pregnant. Based on the highly successful seven German editions of this reference, the up-to-date drug listings have been revised into a handy pocket guide color tabbed for quick access to important information. Easy to reference each drug is listed discussing the side effects, general impact on organ systems, potential toxicity, and risks before offering dosage recommendati.
530 ▼a Issued also as a book.
538 ▼a Mode of access: World Wide Web.
650 0 ▼a Pregnant women ▼x Drug use.
650 0 ▼a Pregnant women ▼x Medical care.
650 0 ▼a Obstetrical pharmacology ▼v Handbooks, manuals, etc.
650 0 ▼a Fetus ▼x Effect of drugs on ▼v Handbooks, manuals, etc.
650 0 ▼a Newborn infants ▼x Effect of drugs on ▼v Handbooks, manuals, etc.
650 2 ▼a Infant, Newborn.
700 1 ▼a Schaefer, Christof.
700 1 ▼a Peters, P. W. J. ▼q (Paul W. J.).
700 1 ▼a Miller, Richard K. ▼q (Richard Kermit), ▼d 1946-.
776 0 8 ▼i Print version: ▼t Drugs during pregnancy and lactation. ▼b 2nd ed. ▼d Amsterdam ; London : Elsevier, 2007 ▼z 9780444520722 ▼z 0444520724 ▼w (OCoLC)170029613
856 4 0 ▼3 ScienceDirect ▼u https://oca.korea.ac.kr/link.n2s?url=http://www.sciencedirect.com/science/book/9780444520722
880 0 0 ▼6 505-01/(S ▼g 2.3.12. ▼t Non-selective ←(Sb←(B-adrenergic agonists -- ▼g 2.4. ▼t Antiemetics -- ▼g 2.4.1. ▼t Nausea and vomiting in pregnancy -- ▼g 2.4.2. ▼t Diet manipulations and treatment -- ▼g 2.4.3. ▼t Complementary treatment options -- ▼g 2.4.4. ▼t Acupuncture and acupressure -- ▼g 2.4.5. ▼t Hypnosis -- ▼g 2.4.6. ▼t Ginger -- ▼g 2.4.7. ▼t Antihistamines (H[sub(1)]-blockers) -- ▼g 2.4.8. ▼t Dopamine antagonists -- ▼g 2.4.9. ▼t Pyridoxine (vitamin B[sub(6)]) -- ▼g 2.4.10. ▼t Thiamine (vitamin B[sub(1)]) -- ▼g 2.4.11. ▼t Serotonin antagonists -- ▼g 2.4.12. ▼t Glucocorticoids -- ▼g 2.4.13. ▼t Other agents with antiemetic properties -- ▼g 2.5. ▼t Gastrointestinal and antilipidemic agents and spasmolytics.
945 ▼a KLPA
991 ▼a E-Book(소장)

소장정보

No. 소장처 청구기호 등록번호 도서상태 반납예정일 예약 서비스
No. 1 소장처 중앙도서관/e-Book 컬렉션/ 청구기호 CR 618.32 등록번호 E14003210 도서상태 대출불가(열람가능) 반납예정일 예약 서비스 M

컨텐츠정보

목차

Front cover; Drugs During Pregnancy and Lactation, Second edition; Copyright page; Contents; List of contributors; Preface; Notice; Chapter 1 General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics in pregnancy; 1.8 Passage of drugs to the unborn and fetal kinetics; 1.9 Causes of developmental disorders
1.10 Embryo/fetotoxic risk assessment1.11 Classification of drugs used in pregnancy; 1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety (or otherwise) of drugs already used in pregnancy; 1.16 Teratology information centers; Chapter 2 Specific drug therapies during pregnancy; 2.1 Analgesics and anti-inflammatory drugs; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Aspirin (acetylsalicylic acid); 2.1.3 Pyrazolone derivatives
2.1.4 Combination analgesic preparations2.1.5 Opioid analgesics in general; 2.1.6 Morphine; 2.1.7 Codeine; 2.1.8 Pethidine (meperidine); 2.1.9 Fentanyl, alfentanil, remifentanil, and sufentanil; 2.1.10 Other narco-analgesics and centrally acting analgesics; 2.1.11 Naloxone; 2.1.12 Nonsteroidal anti-inflammatory drugs (NSAIDs); 2.1.13 Selective cyclooxygenase-2 (COX-2) inhibitors; 2.1.14 Migraine medications; 2.1.15 Additional analgesics; 2.1.16 Additional antiphlogistics and antirheumatics; 2.1.17 Myotonolytics; 2.1.18 Gout interval therapy; 2.1.19 Gout attack therapy
2.2 Antiallergic drugs and desensitization2.2.1 Antihistamines (H[sub(1)]-blocker); 2.2.2 Glucocorticosteroids; 2.2.3 Mast cell stabilizers; 2.2.4 Immunotherapy; 2.3 Antiasthmatic and cough medication; 2.3.1 Asthma and pregnancy; 2.3.2 Selective β[sub(2)]-adrenergic agonists; 2.3.3 Corticosteroids; 2.3.4 Anticholinergic drugs; 2.3.5 Theophylline; 2.3.6 Cromoglycate, nedocromil, and lodoxamide; 2.3.7 Other mast cell inhibitors; 2.3.8 Antileukotrienes; 2.3.9 Monoclonal antibodies and other asthma medications; 2.3.10 Expectorants and mucolytic agents; 2.3.11 Antitussives
2.3.12 Non-selective β-adrenergic agonists2.4 Antiemetics; 2.4.1 Nausea and vomiting in pregnancy; 2.4.2 Diet manipulations and treatment; 2.4.3 Complementary treatment options; 2.4.4 Acupuncture and acupressure; 2.4.5 Hypnosis; 2.4.6 Ginger; 2.4.7 Antihistamines (H[sub(1)]-blockers); 2.4.8 Dopamine antagonists; 2.4.9 Pyridoxine (vitamin B[sub(6)]); 2.4.10 Thiamine (vitamin B[sub(1)]); 2.4.11 Serotonin antagonists; 2.4.12 Glucocorticoids; 2.4.13 Other agents with antiemetic properties; 2.5 Gastrointestinal and antilipidemic agents and spasmolytics
2.5.1 Gastritis and peptic ulcer during pregnancy

관련분야 신착자료

Merrow, A. Carlson (2022)
대한산부인과내분비학회 (2022)
김양진 (2022)
Kestly, Theresa A (2021)
Nair, Balakrishnan Kichu R (2021)
American Academy of Pediatrics. Committee on Infectious Diseases (2021)